Product Name | NebuSelect™ Recombinant Cynomolgus CD30/TNFRSF8, His-tag |
---|---|
Catalog Number | NBL-240678 |
Alias/Synonyms | CD30/TNFRSF8 |
Appearance | see COA |
Molecule Weight | Ala27-Pro394 |
CAS | N/A |
Solubility | Water Soluble |
Storage | Short term 4℃; Long term -20℃. |
Shelf Life | 2 years |
Additional info 1 | A0A2K5VW07 |
Additional info 2 |
Catalog Numbe | Size | Price | Inventory Level | |
NBL-240678-100ug | 100ug | Inquire | Inquire | |
NBL-240678-1mg | 1mg | Inquire | Inquire | |
NBL-240678-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Cynomolgus CD30/TNFRSF8, His-tag
Catalog#:
NBL-240678
Description:
NebuSelect™ Recombinant Cynomolgus CD30/TNFRSF8, His-tag(Cat#NBL-240678) is expressed in HEK293 with His tag at the C-Terminus.It contains Ala27-Pro394.
Species:
Cynomolgus
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 39.86 kDa. Due to glycosylation, the protein migrates to 75-105 kDa based on Bis-Tris PAGE result.
Target Name:
CD30/TNFRSF8
Target Information:
The transmembrane receptor CD30 (TNFRSF8) and its ligand CD30L (CD153, TNFSF8) are members of the tumor necrosis factor (TNF) superfamily and display restricted expression in subpopulations of activated T-and B-cells in nonpathologic conditions. CD30 expression is upregulated in various hematological malignancies, including Reed-Sternberg cells in Hodgkin's disease (HD), anaplastic large cell lymphoma (ALCL) and subsets of Non-Hodgkin's lymphomas (NHLs).
Amino Acid Sequence:
Ala27-Pro394
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.